Cian Healthcare Profit & Loss Annual

BSE: 542678 | NSE: - | ISIN: INE05BN01019 | Sector: Biotechnology & Drugs

3.82 +0.07 (1.87%)Updated : 16 May 2025

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	61.70	68.59	77.87	73.73
Total Revenue	61.70	68.59	77.87	73.73
Costof Revenue Total	30.75	33.44	47.91	40.47
Gross Profit	30.95	35.15	29.96	33.26
Selling/ General/ Admin Expenses Total	13.54	16.85	18.14	14.31
Depreciation/ Amortization	5.47	5.43	4.27	3.45
Unusual Expense( Income)	0.00	-0.11	0.07	0.21
Other Operating Expenses Total	6.55	5.92	7.57	7.16
Total Operating Expense	56.29	61.53	77.97	65.60
Operating Income	5.40	7.06	-0.10	8.13
Interest Inc( Exp) Net- Non- Op Total	-5.27	-5.17	-6.05	-7.28
Other Net	-0.07	0.10	0.15	-0.16
Net Income Before Taxes	0.05	1.99	-6.00	0.69
Provisionfor Income Taxes	-0.20	-0.04	-0.47	0.63
Net Income After Taxes	0.25	2.03	-5.53	0.05
Net Income Before Extra Items	0.25	2.03	-5.53	0.05
Net Income	0.25	2.03	-5.53	0.05
Income Availableto Com Excl Extra Ord	0.25	2.03	-5.53	0.05
Income Availableto Com Incl Extra Ord	0.25	2.03	-5.53	0.05
Diluted Net Income	0.25	2.03	-5.53	0.05
Diluted Weighted Average Shares	2.54	2.51	2.39	2.66
Diluted EPS Excluding Extra Ord Items	0.10	0.81	-2.32	0.02
Diluted Normalized EPS	0.10	0.78	-2.30	0.07
period Length	12.00	12.00	12.00	12.00
period Type	-	-	-	-
Total Adjustmentsto Net Income	-	-	0.00	-